RCEL
AVITA Medical Inc
Price:  
10.30 
USD
Volume:  
71,376.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVITA EV/EBITDA

-338.8%
Upside

As of 2024-11-03, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -6.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 291.23 mil USD. AVITA's TTM EBITDA according to its financial statements is -44.70 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.9x - 15.1x 11.4x
Forward P/E multiples 12.8x - 17.6x 16.1x
Fair Price (22.95) - (26.91) (24.60)
Upside -322.8% - -361.2% -338.8%
10.30 USD
Stock Price
(24.60) USD
Fair Price

AVITA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-28 -6.64
2024-10-25 -6.42
2024-10-24 -6.42
2024-10-23 -6.57
2024-10-22 -6.71
2024-10-21 -6.64
2024-10-18 -6.71
2024-10-17 -6.61
2024-10-16 -6.74
2024-10-15 -6.59
2024-10-14 -6.58
2024-10-11 -6.52
2024-10-10 -6.28
2024-10-09 -6.41
2024-10-08 -6.42
2024-10-07 -6.61
2024-10-04 -6.82
2024-10-03 -6.80
2024-10-02 -6.93
2024-10-01 -6.66
2024-09-30 -6.76
2024-09-27 -6.77
2024-09-26 -6.68
2024-09-25 -6.58
2024-09-24 -6.67
2024-09-23 -6.67
2024-09-20 -6.85
2024-09-19 -6.82
2024-09-18 -6.59
2024-09-17 -6.49
2024-09-16 -6.49
2024-09-13 -6.49
2024-09-12 -6.17
2024-09-11 -6.09
2024-09-10 -5.99
2024-09-09 -5.80
2024-09-06 -5.67
2024-09-05 -5.70
2024-09-04 -5.77
2024-09-03 -5.52
2024-08-30 -5.97
2024-08-29 -5.82
2024-08-28 -5.82
2024-08-27 -5.85
2024-08-26 -5.99
2024-08-23 -5.96
2024-08-22 -5.63
2024-08-21 -5.89
2024-08-20 -5.68
2024-08-19 -5.81